2001
DOI: 10.1161/01.cir.103.3.448
|View full text |Cite
|
Sign up to set email alerts
|

Angiotensin II–Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice

Abstract: Background-Angiotensin II may contribute to the development and progression of atherosclerotic lesions because of its growth and proinflammatory effects. We sought to determine whether angiotensin II-induced hypertension would augment and accelerate the development of atherosclerotic lesions in apoE-deficient mice. Methods and Results-Angiotensin II (0.7 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 SC) was administered to apoE-deficient mice via osmotic minipumps. The animals were placed on either standard chow or an atherogenic diet. A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

21
247
3
3

Year Published

2007
2007
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 332 publications
(274 citation statements)
references
References 53 publications
(38 reference statements)
21
247
3
3
Order By: Relevance
“…As expected from previous reports [1,16,17], this A-II dose caused mild increases in atherosclerotic lesions in the ascending and descending aortae, as well as aneurysm formation in the suprarenal aorta. Percent-aortic lesion areas for individual mice in each group are shown in Figure 1, along with representative oil red O-stained aortae.…”
Section: A-ii Infusion Increases Development Of Atherosclerotic Lesionssupporting
confidence: 90%
See 1 more Smart Citation
“…As expected from previous reports [1,16,17], this A-II dose caused mild increases in atherosclerotic lesions in the ascending and descending aortae, as well as aneurysm formation in the suprarenal aorta. Percent-aortic lesion areas for individual mice in each group are shown in Figure 1, along with representative oil red O-stained aortae.…”
Section: A-ii Infusion Increases Development Of Atherosclerotic Lesionssupporting
confidence: 90%
“…The establishment of a mouse model for A-II-induced AS in genetically modified hyperlipidemic mice has been a major advance, facilitating mechanistic studies of A-II-induced inflammatory signaling [1,16,17]. Although many studies have employed the C57BL/6J apolipoprotein E-deficient (apo E −/− ) mouse, these mice show rapid AS progression, due to large increases in circulating chylomicrons and VLDL remnants [18].…”
Section: Introductionmentioning
confidence: 99%
“…These lesions progress with age in chow‐fed mice, such as used in the present study. Interventions such as a high‐fat, high‐cholesterol diet,20 infusion of Ang II,6, 8 and unilateral RAS10, 11, 16, 21 have been shown to accelerate lipid deposition in this area.…”
Section: Resultsmentioning
confidence: 99%
“…One potential explanation for the lack of benefit in these trials is that renal ischemia causes irreversible atherogenic changes and that restoration of renal blood flow has no effect on mitigating the damage to the vasculature 4. Biological plausibility of this hypothesis is provided by numerous studies showing that decreased renal perfusion is associated with RAS activation,5 and data from animal models showing that even short‐term elevation in angiotensin II (Ang‐II) levels can accelerate the development of atherosclerosis and lead to changes in the arterial wall that persist even after Ang‐II levels return to baseline 6, 7, 8, 9, 10, 11. In addition, RAS has been shown to result in elevated oxidative stress, sympathoadrenergic activation, and impaired vasoactive responses, both within the kidney and the systemic microcirculation 12, 13…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] AngII-induced atherosclerosis is characterized by intimal infiltration of leukocytes that become engorged with lipid. In contrast, AngII induction of AAAs is characterized by medial destruction, macrophage infiltration, thrombus formation, and vascular remodeling.…”
mentioning
confidence: 99%